Hologic, Inc. HOLX GYN Surgical is expected to have registered vital contributions from MyoSure and the Related fluid system, with an increasing contribution from its laparoscopic portfolio.
Hologic’s MyoSure device/procedure is also a solution for fibroid removal, though this is done through tissue removal rather than tissue ablation. “We believe that while there could become ...
Hologic is asking women to #BustTheMyth this Breast Cancer Awareness Month. The provider of breast health products has put a set of myths about cancer, such as the belief women without a family ...
Growth in the GYN Surgical arm is expected to have been fueled by MyoSure and the related Fluent Fluid Management System. Hologic is also likely to have gained from its Laparoscopy business ...
Hologic (HOLX) closed at $79.77 in the latest trading session, marking a -0.98% move from the prior day. This move lagged the S&P 500's daily gain of 0.01%. Meanwhile, the Dow experienced a rise ...